observational-retrospective and prospective
Otherobservational-retrospective and prospective
NCT Number: NCT06248944
Multicentre, retrospective and prospective observational study aimed to set-up a clinical Italian registry in order to collect information on carcinoma of the Head and Neck.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Fondazione del Piemonte per l'Oncologia - IRCCS, Candiolo, Italy
The registry plans to collect data on all patients treated or followed for Head and Neck cancer by the HCP of selected investigational sites in Italy.
Data will be entered manually by HCP staff of each investigational site in the study e-CRF in order to populate the AIR study database. Authorized HCPs will be provided with personal UserID and Password for the access to study eCRF.
For Data analysis an open-source system called Vantage6 will be used. It is a privacy preserving federated learning infrastructure for the secure exchange and analysis of incorporating data located at different sources. Queries will be issued to interrogate the database in order to have descriptive statistics and relevant information to plan the statistical analyses envisioned by the study protocol.
The registry data will support observational studies based on the second hand use of available data. Data collected for the AIR Study could be used also for global collaborative studies performed in Europe and outside the Europe.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
observational-retrospective and prospective
Time frame: From the enrollment to the end of the study (5 years)
To document types of diagnostic and treatment patterns by all stages of disease and frequency, and proportion with which they are used in the different stages of Head and Neck cancer.
Time frame: From the enrollment to the end of the study (5 years)
To estimate the proportion of patients in the different stage of disease (TNM staging system 8^ edition) in the overall Head and Neck cancer patient population.
Time frame: From the enrollment to the end of the study (5 years)
To assess treatment outcomes in all patients by stage of disease
Time frame: From the enrollment to the end of the study (5 years)
To describe patients and disease characteristics (considering possibility of familiar occurrence).
Time frame: From the enrollment to the end of the study (5 years)
To find benchmark values for selected indicators (i.e., number of retrieved nodes, surgical complication, etc.) for surgical treatment
Time frame: From the enrollment to the end of the study (5 years)
To evaluate healthcare resource utilization in the total population
Time frame: From the enrollment to the end of the study (5 years)
To identify independent significant host-related prognostic factors and establish a more detailed prognostic classification for the growing population of Head and Neck cancer patients
Time frame: From the enrollment to the end of the study (5 years)
To prove the relationship between differences in mortality and differences in medical practice or medical organizations (subspecialty of the surgeon; type of hospital; management in the cancer network; conformity with clinical practice guidelines)
Time frame: From the enrollment to the end of the study (5 years)
To investigate the potential benefit for survival by classifying the detection of metastasis as early or late discoveries and by calculation of overall survival probabilities for both categories
Time frame: From the enrollment to the end of the study (5 years)
To determine the influence of immunization with vaccines preceding the removal of the primary tumor on prognosis of Head and Neck cancer patients, adjusting for stage, primary site, age, sex, particular treatment methods or patterns of referral
Time frame: From the enrollment to the end of the study (5 years)
To assess the links between costs and health outcomes using an econometric approach, taking into account confounding factors (stage, performance status, comorbidities, etc.).
Italian Head&Neck Society
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07285044
Adenocarcinoma, Adnexal Diseases
Jacksonville, Florida, United States
View Trial DetailsNCT05334069
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Anchorage, Alaska, United States
View Trial DetailsNCT04151082
Cranial Nerve Diseases, Cranial Nerve Disorder
Houston, Texas, United States
View Trial DetailsNCT00991094
Breast Carcinoma, Breast Diseases
Houston, Texas, United States
View Trial Details